TICKERNERD
Menu
QSIQSIHealthcare · Medical Devices

QSI Stock Forecast: Quantum-Si, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$0.74
−6.35% on the day

The 3 Wall Street analysts covering Quantum-Si, Inc. hold a median 12-month price target of $2.5 — +237.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 31 of 100 as at 15 Aug 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$161.1M
Ticker Nerd rank
31 / 100
Median analyst target
$2.50
Analysts covering
3
Total return, dividends reinvested
1W
−9.1%
1M
−14.6%
YTD
−32.7%
1Y
−33.9%
From 52W high
−71.9%
From 52W low
+5.4%
$0.70
$2.63
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

QSI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Quantum-Si, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Aug 2026
31 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
81
Size
71
Issuance
62
Accruals
57
Revisions
54
Quality
17
Volatility
14
Value
13
Momentum
7

Growth (81): Sales and profits are climbing, and climbing faster than before.

Momentum (7): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

QSI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on QSI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.00$2.00$3.00$4.00Oct 25Jan 26Apr 26Jul 26QSIHigh $4.00Median $2.50Low $1.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says3 analysts
2 Buy1 Hold0 Sell
Low $1.00Median $2.50High $4.00

The green dot is the last close — the median target sits +237.9% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
5 Mar 2026Canaccord GenuityMaintainsHold$1.50 → $1.00
5 Mar 2026Canaccord GenuityMaintainsHold—
22 Dec 2025Canaccord GenuityMaintainsHold—
27 Oct 2025Canaccord GenuityMaintainsHold—
9 Sept 2025Canaccord GenuityMaintainsHold—
19 May 2025HC Wainwright & Co.ReiteratesBuy—
7 Feb 2025Alliance Global PartnersInitiatesBuy—
14 Jan 2025HC Wainwright & Co.ReiteratesBuy—
21 Nov 2024HC Wainwright & Co.MaintainsBuy—
13 Nov 2024Canaccord GenuityMaintainsHold—
13 Nov 2024HC Wainwright & Co.ReiteratesBuy—
10 May 2024HC Wainwright & Co.ReiteratesBuy—
1 Mar 2024HC Wainwright & Co.MaintainsBuy—
8 Dec 2023HC Wainwright & Co.InitiatesBuy—
25 Sept 2023Canaccord GenuityDowngradeHold—
20 Oct 2021Canaccord GenuityInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. QSI appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

QSI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

Quantum-Si, Inc. (QSI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−1.5×

Cheaper than 84% of US stocks

Price / sales
100.9×

Cheaper than 4% of US stocks

Price / book
0.8×

Cheaper than 78% of US stocks

EV / EBITDA
−0.6×

Cheaper than 65% of US stocks

Growth & margins
Revenue growth (YoY)
−41.8%

Higher than 6% of US stocks

Earnings growth (YoY)
—
Gross margin
28.7%

Higher than 33% of US stocks

Operating margin
−7450.3%

Higher than 2% of US stocks

Net margin
47.3%

Higher than 96% of US stocks

Returns & dividend
Return on equity
−49.1%

Higher than 21% of US stocks

Return on assets
−26.5%

Higher than 16% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

QSI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
QSIQuantum-Si, Inc.$161.1M
31
INGNInogen, Inc.$156.6M
91
MXCTMaxCyte, Inc.$141.4M
73
OWLTOwlet, Inc.$193.1M
40
LUCDLucid Diagnostics, Inc.$196.5M
49
APYXApyx Medical Corp.$124.3M
69
QTRXQuanterix Corp.$122.0M
27

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Quantum-Si, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest QSI news & analysis

Quantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript

Seeking Alpha · 14 Aug 2026neutral

Quantum-Si, Inc. (QSI) held its Q2 2026 earnings call, the transcript of which was published by Seeking Alpha. The item reports that the company's second-quarter earnings call took place and its full transcript is now available to readers.

Why it matters — A QSI watcher would care because the earnings call transcript provides the company's own commentary and updates on its second-quarter performance and outlook.

Quantum-Si Q2 Earnings Call Highlights

MarketBeat · 14 Aug 2026negative

Quantum-Si (NASDAQ: QSI) announced that the planned launch of its Proteus protein sequencing platform has been moved to the second quarter of 2027 from the end of 2026, citing the need for an additional integrated instrument design cycle before production. The company also disclosed a targeted workforce reduction of about 20% to lower cash burn and fund the revised development timeline.

Why it matters — A QSI watcher would care because the delayed Proteus launch and 20% workforce reduction signal a longer development timeline and cost-cutting measures that affect the company's cash position and near-term progress.

Quantum-Si Incorporated (QSI) Reports Q2 Loss, Tops Revenue Estimates

Zacks Investment Research · 13 Aug 2026positive

Quantum-Si Incorporated reported a Q2 quarterly loss of $0.11 per share, narrower than the Zacks Consensus Estimate of a $0.13 loss and an improvement from the $0.16 per share loss a year ago. The company's results beat revenue estimates.

Why it matters — QSI watchers would note the company's quarterly loss narrowed year over year and came in better than analysts expected.

Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update

GlobeNewsWire · 13 Aug 2026neutral

Quantum-Si reported Q2 2026 financial results and pushed the commercial launch of its Proteus platform to Q2 2027, while implementing cost-reduction measures that are expected to extend its cash runway into Q4 2028.

Why it matters — The Proteus launch delay and cost-cutting actions directly affect Quantum-Si's path to revenue generation and financial runway, key factors for shareholders monitoring the company's commercial progress.

Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026

GlobeNewsWire · 27 July 2026neutral

Quantum-Si announced it will report its second quarter 2026 financial results on August 13, 2026.

Why it matters — This announcement provides a scheduled date for QSI's next financial disclosure, which investors and analysts will watch for updates on the company's performance and progress.

FAQ

Frequently asked questions about QSI stock

What is the QSI stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Quantum-Si, Inc. have a median 12-month price target of $2.5, with estimates ranging from $1 to $4. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is QSI stock a buy right now?

Of the 3 analysts covering Quantum-Si, Inc., 2 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Quantum-Si, Inc. 31 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank QSI?

As at 15 Aug 2026, Quantum-Si, Inc. ranks 31 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (81 of 100).

Will QSI stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +237.9% from the last close, and Ticker Nerd's factor model ranks Quantum-Si, Inc. 31 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the QSI stock forecast for 2030?

No analyst covering Quantum-Si, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for QSI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $1 to $4 over the next 12 months.

How has QSI stock performed over the past year?

Quantum-Si, Inc. returned -33.9% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Quantum-Si, Inc. do?

Quantum-Si Incorporated is a life sciences company pioneering next-generation protein sequencing (NGPS) through its proprietary single-molecule detection platform. This technology enables researchers to sequence proteins at the single amino acid level, providing unprecedented insights into proteomics for applications such as antibody characterization, biomarker identification, protein variant analysis, and post-translational modification studies.

What is the latest news on QSI?

The most recent item we track (Seeking Alpha, 14 Aug 2026): "Quantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript". Quantum-Si, Inc. (QSI) held its Q2 2026 earnings call, the transcript of which was published by Seeking Alpha. The item reports that the company's second-quarter earnings call took place and its full transcript is now available to readers.

Company

About Quantum-Si, Inc.

Quantum-Si Incorporated is a life sciences company pioneering next-generation protein sequencing (NGPS) through its proprietary single-molecule detection platform. This technology enables researchers to sequence proteins at the single amino acid level, providing unprecedented insights into proteomics for applications such as antibody characterization, biomarker identification, protein variant analysis, and post-translational modification studies. The company's flagship products include the Platinum and Platinum Pro NGPS instruments, which offer streamlined workflows, automated data analysis, enhanced user interfaces, and options for cloud or on-instrument processing, making advanced protein analysis accessible to labs of all types. Complementary consumables encompass Library Preparation Kits, Barcoding Kits, and Sequencing Kits, along with Platinum Analysis Software for intuitive visualization and workflow automation. By merging semiconductor technology, biology, chemistry, and artificial intelligence, Quantum-Si Incorporated advances the post-genomic era, empowering breakthroughs in drug discovery and diagnostics. Founded in 2013 and headquartered in Branford, Connecticut, it focuses on revolutionizing protein research worldwide.

CEO Mr. Jeffrey Alan Hawkins · 145 employees · United States · https://www.quantum-si.com